89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $721,146 | -23.0% | 64,561 | +6.4% | 0.00% | -50.0% |
| Q3 2023 | $936,961 | +218.3% | 60,684 | +290.7% | 0.00% | +100.0% |
| Q2 2023 | $294,331 | -60.5% | 15,532 | -68.3% | 0.00% | -50.0% |
| Q1 2023 | $745,524 | -19.7% | 48,951 | -32.9% | 0.00% | 0.0% |
| Q4 2022 | $928,641 | +608.9% | 72,949 | +222.8% | 0.00% | – |
| Q3 2022 | $131,000 | – | 22,602 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 400,000 | $1,288,000 | 6.98% |
| TCG Crossover Management, LLC | 1,133,196 | $3,649,000 | 1.55% |
| GREAT POINT PARTNERS LLC | 1,400,000 | $4,508,000 | 1.08% |
| DAFNA Capital Management LLC | 766,774 | $2,469,000 | 0.67% |
| RA Capital Management | 7,782,669 | $25,060,000 | 0.67% |
| BVF INC/IL | 3,898,000 | $12,552,000 | 0.61% |
| Boxer Capital, LLC | 1,400,000 | $4,508,000 | 0.29% |
| Orbimed Advisors | 3,658,869 | $11,782,000 | 0.21% |
| Newtyn Management, LLC | 310,000 | $998,000 | 0.19% |
| Orchard Capital Management, LLC | 168,493 | $592,000 | 0.18% |